COVID: DELTA VARIANT, now it’s more DANGEROUS! These are the SYMPTOMS and all the INFORMATION to recognize it
The Delta VARIANT threatens EuropeNow it is confirmed: the DELTA VARIANT (formerly Indian variant) is more contagious and leads to more hospital. Public Health England’s (PHE) periodic analysis published on June 3 finds that the Delta variant has become prevalent in Britain, it is around 50% more transmissible than the Alfa variant (formerly English) and increases the risk of hospitalization by 2 and a half times.
almost confirmed variant in the UK they rose to 12,431, compared to 6,959 the week before and represent up to 75% of new coronavirus cases. Compared to higher transmissibility, Delta’s PHE estimate of Secondary Attack Rate (SAR) has dropped, from 67% higher than Alpha in last week’s report, to + 50% this week. The SAR tells us how likely someone is to infect one of its close contacts, so Delta confirms its potential greater contagiousness. What SYMPTOMS does the DELTA VARIANT have? At the level of symptoms, as we read in Il Messaggero, it seems to have more impact on the body. Coughs, colds, headaches and sore throats, fever, body aches, diarrhea, fatigue and exhaustion – the first signs of coronavirus in people – are usually stronger. And consequently the healing times are also affected.
As for the VACCINES resistance has yet to be demonstrated. According to initial data from Israel, the Pfizer-BioNTech vaccineit is partially effective against the former Indian variant and early neutralization tests on the Indian Covaxin vaccine also showed a good response. According to the virologist Giovanni Maga, director of the Institute of molecular genetics of the Cnr of Pavia, “There is a study by an Indian group in which researchers show that the investigational Indian vaccine protects against this variant, and is a similar vaccine to the Chinese one, based on the inactivated virus. The study is currently under review for publication but the data have already been made available on a public database so that the scientific community could already evaluate them “.